Hosted on MSN1d
Merit Medical Celebrates FDA Approval of WRAPSODY™An update from Merit Medical Systems ( ($MMSI) ) is now available. On January 28, 2025, Merit Medical Systems held a conference call to discuss ...
A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...
Since the announcement that president-elect Donald Trump would nominate Robert F. Kennedy Jr. (RFK Jr.) as the secretary of the U.S. Department ...
Needham analyst Michael Matson has reiterated their bullish stance on AORT stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...
Hosted on MSN23h
TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000%Three nano-cap healthcare stocks drew massive attention from retail investors on Stocktwits Tuesday, though not all for ...
Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious ...
GlobalData on MSN2d
Stereotaxis wins European approval for robotic ablation catheterStereotaxis has won European CE mark approval for its MaGiC ablation catheter, a robotically navigated device for the ...
Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...
Stockhead on MSN23h
Phase III Trials: It’s crunch time for these ASX health stocksSeveral ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...
Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced a significant milestone: the treatment ...
Accomplished Business and Financial Leader, Laura Brege, Appointed Chair ---- Paul J. Hastings and Andreas Wicki, PhD Retire from Board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback